A Study to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics and the Effect of Probenecid on Povorcitinib Pharmacokinetics When Administered Orally to Healthy Adult Participants

• Status: COMPLETED
• Trial end date: 2025-01-15

Summary

The purpose of this study is to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics and the Effect of Probenecid on Povorcitinib Pharmacokinetics When Administered Orally to Healthy Adult Participants.

• Phase: PHASE1

Details

• Lead Sponsor: Incyte Corporation
• Treatments: Digoxin; Metformin; Probenecid; Rosuvastatin Calcium